The ICD-10-CM (International Classification of Diseases, Tenth Revision, Clinical Modification) is a system used by physicians and other healthcare providers to classify and code all diagnoses, symptoms and procedures recorded in conjunction with hospital care in the United States.
The ICD-10-CM is a catalog of diagnosis codes used by medical professionals for medical coding and reporting in health care settings. The Centers for Medicare and Medicaid Services (CMS) maintain the catalog in the U.S. releasing yearly updates.
Why ICD-10 codes are important
ICD-10-CM Diagnosis Code R97 R97.
Hemoglobin E-beta thalassemia D56. 5 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM D56. 5 became effective on October 1, 2021.
Hemoglobin E (HbE) is an extremely common structural hemoglobin variant that occurs at high frequencies throughout many Asian countries. It is a β-hemoglobin variant, which is produced at a slightly reduced rate and hence has the phenotype of a mild form of β thalassemia.
Hemoglobin E trait (AE) is an inherited condition which affects the hemoglobin in your red blood cells. • Hemoglobin is a protein in red blood cells. The job of hemoglobin is to carry oxygen through the body.
ICD-10-CM Diagnosis Code R97 R97.
Code D64. 9 is the diagnosis code used for Anemia, Unspecified, it falls under the category of diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism. Anemia specifically, is a condition in which the number of red blood cells is below normal.
Hb E/β-thalassemia is a common disease in Thailand and parts of Southeast Asia. It results in a variable clinical picture similar to that of homozygous β-thalassemia, ranging from a condition indistinguishable from thalassemia major to a mild form of thalassemia intermedia.
People with hemoglobin E trait do not have hemoglobin E disease or hemoglobin E/beta thalassemia disease. They cannot develop these diseases later in life.
Hemoglobin E trait is caused by a gene defect and is rare. People with hemoglobin E trait usually have no symptoms. Most people with hemoglobin E disease will live a healthy, normal life.
What is hemoglobin E Trait? Hemoglobin E trait is an inherited blood disorder. That means it is passed down through your parent's genes. It leads to an abnormal form of hemoglobin that may cause mild anemia. It occurs most often in people of Southeast Asian descent.
Homozygous Hemoglobin E (phenotype: FEE in infants and EE in adults) Homozygous hemoglobin E results when the gene for hemoglobin E is inherited from both parents. A mild thalassemia phenotype develops in the first few months of life as the amount of fetal hemoglobin decreases and hemoglobin E increases.
Disease at a Glance It is inherited in an autosomal recessive manner and is caused by a genetic change in the HBB gene. The genetic change that causes Hemoglobin E disease primarily occurs in Southeast Asian populations, and rarely in Chinese populations.
Hemoglobins characterized by structural alterations within the molecule. The alteration can be either absence, addition or substitution of one or more amino acids in the globin part of the molecule at selected positions in the polypeptide chains.
A disease characterized by compensated hemolysis with a normal hemoglobin level or a mild to moderate anemia. There may be intermittent abdominal discomfort, splenomegaly, and slight jaundice. A group of inherited disorders characterized by structural alterations within the hemoglobin molecule.
The 2022 edition of ICD-10-CM D58.2 became effective on October 1, 2021.